MYD88 and diffuse large B-cell lymphoma: The seven mutated cases had the L265P mutation, which is the most recurrently found MYD88 mutation, it has been demonstrated to be an activating mutation leading to NFkB activation [30–33] and more frequently found in non-GCB DLBCL [34–35].